Afatinib vs Empagliflozin

## Afatinib vs Empagliflozin: Overview

This comparison examines the pharmacological differences between **Afatinib** and **Empagliflozin**.

## Mechanism of Action

**Afatinib**: Irreversible covalent inhibitor of ErbB family (EGFR/HER1, HER2, HER4) tyrosine kinases.

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

## Pharmacokinetics

**Half-life**: Afatinib — 37 hours; Empagliflozin — 12.4 hours.

## Chemical Properties

**Molecular Formula**: Afatinib — C24H25ClFN5O3; Empagliflozin — C23H27ClO7.

**Molecular Weight**: Afatinib — 485.9400 g/mol; Empagliflozin — 450.9100 g/mol.

**Type**: Afatinib — Small molecule; Empagliflozin — Small molecule.